Origin Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Origin Asset Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-38,940	Closed	-$3.86M	–	98
2019 Q2	$3.86M	Sell	38,940 -147,100	-79%	-$14M	0.43%	64
2019 Q1	$20.5M	Sell	186,040 -4,640	-2%	-$485K	1.72%	19
2018 Q4	$17.5M	Sell	190,680 -47,200	-20%	-$4.78M	1.6%	18
2018 Q3	$26.2M	Sell	237,880 -800	-0.3%	-$83.3K	1.71%	16
2018 Q2	$22.3M	Sell	238,680 -35,400	-13%	-$3.05M	1.58%	21
2018 Q1	$22.7M	Sell	274,080 -8,300	-3%	-$737K	1.43%	26
2017 Q4	$25.7M	Sell	282,380 -1,800	-0.6%	-$150K	1.47%	30
2017 Q3	$21.6M	Sell	284,180 -9,000	-3%	-$680K	1.33%	34
2017 Q2	$22M	Buy	293,180 +139,400	+91%	+$9.66M	1.35%	29
2017 Q1	$10M	Buy	153,780 +38,500	+33%	+$2.27M	0.62%	57
2016 Q4	$6.35M	Buy	115,280 +109,500	+1,894%	+$6.01M	0.42%	79
2016 Q3	$327K	Hold	5,780	–	–	0.02%	114
2016 Q2	$241K	Hold	5,780	–	–	0.02%	123
2016 Q1	$247K	Hold	5,780	–	–	0.02%	121
2015 Q4	$262K	Buy	+5,780	New	+$243K	0.02%	106

Other funds holding PRAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Origin Asset Management's PRAH Position: Q3 2019 in Review

Origin Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2019, closing a stake of 38,940 shares — an estimated $3.86M sold.

Origin Asset Management first reported a position in PRAH in Q4 2015 and held it in 15 quarters. The position peaked at $26.2M in Q3 2018. 329 funds tracked by Wall St. Rank hold PRAH as of Q3 2019.

Origin Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2019 after selling out during the quarter.
Origin Asset Management sold 38,940 PRA Health Sciences, Inc. shares in Q3 2019, an estimated $3.86M.
Origin Asset Management first reported a position in PRA Health Sciences, Inc. in Q4 2015 and held it in 15 quarters.
Origin Asset Management's PRA Health Sciences, Inc. position peaked at $26.2M in Q3 2018.
329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2019.

Based on Origin Asset Management's 13F filing for Q3 2019, filed 29 Oct 2019.